Chronic Kidney Disease Assessment and Management

Understanding Age-Adjusted Kidney Function

Normal GFR in young adults is approximately 120-130 mL/min/1.73 m² but declines physiologically with age beginning in the third or fourth decade of life 1
By the sixth decade, GFR commonly declines by 1-2 mL/min per year as a normal aging process 1
An eGFR of 62 mL/min/1.73 m² represents retention of more than half of normal adult kidney function 2
This value places a patient just above the critical threshold of 60 mL/min/1.73 m², which is the cutoff for defining chronic kidney disease (CKD) 3

A patient with an eGFR of 62 mL/min/1.73 m² is in Stage 2 CKD (G2: 60-89 mL/min/1.73 m²) if kidney damage markers are present, or has normal kidney function for age if no damage markers exist 2
The American Diabetes Association recommends measuring urinary albumin-to-creatinine ratio (UACR) on a random spot urine sample 3
Normal UACR is <30 mg/g creatinine 3
Albuminuria (UACR ≥30 mg/g) is the principal marker of kidney damage and dramatically increases cardiovascular and kidney disease progression risk even with preserved eGFR 2

An eGFR of 62 mL/min/1.73 m² is far above the risk thresholds for increased mortality and cardiovascular complications 2
The American Journal of Kidney Diseases states that eGFR ≥60 mL/min/1.73 m²: No significantly increased cardiovascular or mortality risk from kidney function alone 2
eGFR 45-59 mL/min/1.73 m²: Moderately increased risk 4
eGFR <45 mL/min/1.73 m²: Substantially increased risk of complications and mortality 4
The presence of CKD (eGFR <60 mL/min/1.73 m²) confers approximately 16% increase in cardiovascular mortality, but this risk is heavily modified by albuminuria status 1

The European Heart Journal recommends using the CKD-EPI equation for accurate assessment of eGFR in adults of any age 5
Drug accumulation due to reduced renal excretion is the most important cause of adverse drug reactions in older adults 5
Monitor renal function regularly, as creatinine-based equations can misclassify kidney disease by one stage in >30% of older adults due to reduced muscle mass 5

Serial eGFR measurements over time are more informative than a single value for risk stratification in elderly patients 2
Monitor for rate of eGFR decline: If declining >4-8 mL/min per year, this suggests accelerated kidney disease requiring intervention 1
Blood pressure control: Uncontrolled systolic blood pressure accelerates GFR deterioration 1
Diabetes status: If diabetic, screen for retinopathy as its absence with kidney disease suggests alternative causes 3

The National Kidney Foundation suggests that an eGFR of 115 mL/min/1.73 m² places the patient in Stage 1 kidney function, indicating excellent kidney function, with no chronic kidney disease unless markers of kidney damage are present, such as albuminuria, structural abnormalities, or pathological findings 6, 7
The American Journal of Kidney Diseases recommends reviewing urinalysis for hematuria, proteinuria, or cellular casts that might indicate glomerular or tubular damage not reflected in the eGFR, to confirm truly normal kidney status 6
Assessing for structural abnormalities if previous imaging suggested kidney damage is necessary, as it can indicate kidney disease despite excellent eGFR, according to the American Journal of Kidney Diseases 6
The American Journal of Kidney Diseases notes that eGFR equations tend to underestimate true GFR in the normal range, meaning actual kidney function may be even higher than 115 mL/min/1.73 m² 8
The Annals of Internal Medicine states that no medication dose adjustments are required at this level of kidney function, with drug dosing modifications only becoming necessary when eGFR falls below 60 mL/min/1.73 m² 9

The American Journal of Kidney Diseases recommends that an eGFR decline should be assessed by calculating the rate of decline, with a decline of more than 5 mL/min/1.73 m² per year indicating rapid progression requiring investigation for reversible causes 10
The American Diabetes Association, as published in Diabetes Care, defines normal urinary albumin-to-creatinine ratio (UACR) as less than 30 mg/g creatinine, and recommends repeat testing within 3-6 months if UACR is ≥30 mg/g on initial testing 11
The Mayo Clinic Proceedings recommends measuring UACR on a random spot urine sample immediately to determine whether kidney damage exists, as albuminuria ≥30 mg/g dramatically increases cardiovascular and kidney disease progression risk even with preserved eGFR 12

The American Journal of Kidney Diseases recommends reassessing eGFR and UACR annually, with serial eGFR measurements over time being more informative than a single value for risk stratification 10
The Mayo Clinic Proceedings recommends more frequent testing (twice yearly) if UACR ≥300 mg/g or eGFR drops below 45 mL/min/1.73 m² 12

The Mayo Clinic Proceedings recommends nephrology referral if eGFR drops below 45 mL/min/1.73 m², UACR ≥300 mg/g on repeated testing, or sustained decline in eGFR >5 mL/min/1.73 m² per year 12, 10
The American Journal of Kidney Diseases recommends considering intervention if eGFR drops by 25% or more from baseline with a decline to a lower GFR category 10